期刊文献+

2017年-2019年上海市某三甲医院起搏器植入患者住院费用分析 被引量:6

Analysis of Hospital Expenses of Pacemaker Implantation Patients in a Tertiary-Level Hospital in Shanghai from 2017 to 2019
原文传递
导出
摘要 目的分析心脏起搏器植入患者住院费用构成及变化趋势,为减轻起搏器植入患者直接经济负担提供科学依据.方法收集上海市某三甲医院2017年5月1日-2019年6月30日出院的660例心脏起搏器植入患者的住院费用数据,采用灰色关联法和结构变动度分析住院总费用的关联程度、结构和变动情况.结果从灰色关联来看,与住院总费用关联度最高的是卫生材料费0.7961,其次是化验费0.3580和检查费0.3565,护理费0.3507和治疗费0.3506的关联度较小,分别排在第7和第9位;引起住院总费用结构变动最大的是卫生材料费50%,其次是化验费16.06%和检查费11.50%,累计贡献率达77.56%,2017年-2018年治疗费5.35%、护理费5.27%的结构变动贡献率较2018年-2019年0.34%、1.93%有较大幅度减少.结论卫生材料费是影响起搏器植入患者住院总费用的主要因素,体现医务人员劳动价值的收入项增幅不明显,建议进一步加强卫生材料使用管控,调整医疗服务价格;规范临床路径、建立诊疗规范体系;完善医保支付方式,加快推进疾病诊断相关分组和病种分值付费方式. Objective To analyzes the composition and trend of hospitalization expenses of patients with pacemaker implantation,and provides scientific basis for reducing the direct economic burden of patients with pacemaker implantation.Methods The inpatient cost data of 660 patients with pacemaker implantation discharged from a tertiary-level hospital in Shanghai from May 1,2017 to June 30,2019 were collected,and the correlation degree,structure and change of total inpatient cost were analyzed by using the grey relevancy analysis and structural variation.Results From the perspective of gray correlation,the cost of sanitary materials(0.7961)has the highest degree of correlation with the total hospitalization cost,followed by the cost of laboratory tests(0.3580)and inspection fees(0.3565),and the degree of correlation between nursing costs(0.3507)and treatment costs(0.3506)Smaller,ranked 7 th and 9 th respectively;the largest change in the total hospitalization cost structure is the cost of sanitary materials(50%),followed by laboratory fees(16.06%)and inspection fees(11.50%),with a cumulative contribution rate of up to 77.56%,the contribution rate of structural changes in treatment expenses and nursing expenses has decreased significantly(5.35%and 5.27%in 2017-2018;0.34%and 1.93%in 2018-2019).Conclusion The cost of raw materials is the main factor affecting the total hospitalization cost of patients with pacemaker implantation.The income item reflecting the labor value of medical personnel does not increase significantly.It is suggested to further strengthen the control of the use of sanitary materials.Continue to adjust the prices of medical services;Standardizing clinical pathway and establishing diagnostic and treatment standard system;Improve medical insurance payment methods and accelerate the adoption of DRGs and DIP payment methods.
作者 朱乐兰 袁筱祺 冯运 高玮 Zhu Yuelan;Yuan Xiaoqi;Feng Yun;Gao Wei(Shanghai General Hospital of Nanjing Medical University,Shanghai 200080,China)
出处 《中国病案》 2021年第6期63-66,共4页 Chinese Medical Record
基金 上海交通大学中国医院发展研究院医院管理建设项目(CHDI-2019-B-14)
关键词 心脏起搏器 住院费用 灰色关联分析 结构变动度 Cardiacpacemaker Hospital costs Grey relevancy analysis Degree of structural variation(DSV)
  • 相关文献

参考文献13

二级参考文献80

  • 1王海银,彭颖,贺渊峰,金春林.国内六市现行综合类医疗服务价格比较研究[J].中国卫生经济,2015,34(1):56-59. 被引量:14
  • 2牛巍,赵晨,宋葆芸.基于劳动价值的护理绩效奖金分配模式的探讨[J].中国卫生经济,2015,34(5):89-91. 被引量:16
  • 3王旭.完善医疗收费和药品价格公示制度 加强“阳光医院”建设[J].中国医院管理,2006,26(6):58-58. 被引量:3
  • 4郭继鸿.深入认识心脏再同步化治疗心力衰竭的机制[J].中国心脏起搏与心电生理杂志,2006,20(4):283-284. 被引量:62
  • 5GREGORATOS G,ABRAMS J,EPSTE A E,et al.ACC/-AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices summary article:a report of the American Heart Association Task Forece on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines)[J].Circulation,2002,106(16):2145-2161. 被引量:1
  • 6YONG J B,ABRAHAM W T,SMITH A L,et al.Combined cardiac resynchronization and implantable cardioversion defibrillator in advance chronic heart failure:the MIRACLE ICD trial[J].JAMA,2003,289 (20):2685-2694. 被引量:1
  • 7THE ABTUARRGTTGNUCS VERSUS IMPIANTABLE DEFIBRILLATERE(AV-ID) INVESTIGATORS.A comparison of antiarrhythmic druy therapy with implamtable in patients resuscitated from venticular arrhythmias[J].N Engl J Med,1997,337:1576-1583. 被引量:1
  • 8CONNOLLY S J,GENT M,ROBERTS R S,et al.Canadian implantable defibrillator study (CIDS):a randomized trial of the implantable cardioverter defibrillator against amiodarone[J].Circulation,2000,101 (11):1297-1302. 被引量:1
  • 9KUCK K H,CAPPATO R,SIEBELS J,et al.Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest:The Cardiac.Arrest Study Hamburg(CASH)[J].Circulation,2000,102 (7):748-754. 被引量:1
  • 10BARDY G H,LEE K L,MARK D B,et al.Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure[J].N EnglJ Meal,2005,352 (3):225-237. 被引量:1

共引文献251

同被引文献53

引证文献6

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部